Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MannKind Corporation (MNKD)

  • Event
  • May 12, 2022, 21:12 UTC
  • 9
  • 1 comments

(99% Neutral) MannKind Corporation (MNKD) Announces Regulatory Update

Comment Full text

Mirati Therapeutics Inc (was acquisied by Bristol Myers Squibb (NYSE: BMY) on 23/01/2024) (MRTX)

  • Event
  • May 12, 2022, 21:07 UTC
  • 9
  • 1 comments

(80% Positive) MIRATI THERAPEUTICS, INC. (MRTX) Files Form 8-K

Comment Full text

Cellectis (CLLS)

  • Event
  • May 12, 2022, 20:48 UTC
  • 8
  • 1 comments

(10% Negative) Cellectis (CLLS) Reports Q2 2022 Financial Results (Form 6-K)

Comment Full text

KemPharm Inc (the company was transformed to Zevra (NASDAQ GS: ZVRA)) (KMPH)

  • Event
  • May 12, 2022, 20:48 UTC
  • 9
  • 1 comments

(30% Negative) KemPharm, Inc. (KMPH) Reports Q2 2022 Financial Results

Comment Full text

Cellectis (CLLS)

  • Event
  • May 12, 2022, 20:40 UTC
  • 8
  • 1 comments

(70% Positive) Cellectis (CLLS) Announces Clinical Development Update (Form 6-K)

Comment Full text

Spectrum Pharmaceuticals Inc (was acquised by Assertio Holdings, Inc (NASDAQ:ASRT) on 31/07/2023) (SPPI)

  • Event
  • May 12, 2022, 20:29 UTC
  • 9
  • 1 comments

(30% Negative) SPECTRUM PHARMACEUTICALS INC (SPPI) Reports Q2 2022 Financial Results

Comment Full text

Imago Biosciences Inc (the company became a subdivision of the company Merck (NYSE: MRK)) (IMGO)

  • Event
  • May 12, 2022, 20:28 UTC
  • 9
  • 1 comments

(10% Negative) Imago BioSciences, Inc. (IMGO) Reports Q2 2022 Financial Results

Comment Full text

Adicet Bio Inc (ACET)

  • Event
  • May 12, 2022, 20:18 UTC
  • 9
  • 1 comments

(30% Negative) Adicet Bio, Inc. (ACET) Reports Q2 2022 Financial Results

Comment Full text

Poseida Therapeutics (PSTX)

  • Event
  • May 12, 2022, 20:16 UTC
  • 9
  • 1 comments

(75% Positive) Poseida Therapeutics, Inc. (PSTX) Reports Q2 2022 Financial Results

Comment Full text

Erasca Inc (ERAS)

  • Event
  • May 12, 2022, 20:12 UTC
  • 10
  • 1 comments

(10% Negative) Erasca, Inc. (ERAS) Reports Q2 2022 Financial Results

Comment Full text
  • Previous
  • 220
  • 221
  • 222
  • 223
  • 224
  • Next

Search

News categories

  • Technical Exchange News(10881)
  • Event(2272)
  • SEC News(189491)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124630)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin